Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-075626
Filing Date
2016-01-14
Accepted
2016-01-14 14:11:34
Documents
1
Period of Report
2016-01-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v428961_4.html 4  
1 OWNERSHIP DOCUMENT v428961_4.xml 4 3619
  Complete submission text file 0001144204-16-075626.txt   5027
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CURIS, INC 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address
MCNAB JAMES R (Reporting) CIK: 0001190126 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13341 | Film No.: 161342607